A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a lawsuit filed by his family.

Despite having the power to set the list price for their medications, pharmaceutical companies are driven by profit and ...

ICER assessed GSK's COPD inhalers, Trelegy Ellipta and Breo Ellipta, for Medicare price negotiations, highlighting their once-daily dosing and comparable net health benefits.

Asthma sufferers in the UAE who rely on Ventolin to relieve symptoms are struggling to refill their medication, with many ...

Clinical evidence shows that inhaled CS present early benefits (within 1-2 h) for the treatment of children and adults with acute asthma. Patients (children and adults) who received inhaled CS ...

Optum Rx, a subsidiary of UnitedHealth Group, on Friday filed a motion to dismiss the lawsuit brought by the family of Cole Schmidtknecht.

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

“If it's designing a better pharmaceutical drug for asthma or a respiratory disease, knowing exactly where the inhaled ...

Irish biotech GH Research has said the phase 2 win for its inhaled depression drug has “paved the way for future commercial success.” The inhaled mebufotenin candidate, dubbed GH001 ...